Search Results - "Tunçay, Seçil Conkar"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    What is The Best Choice in Steroid-Dependent Nephrotic Syndrome: Mycophenolate Mofetil Plus Dexamethasone or Cyclosporine A by Tunçay, Seçil, Mir, Sevgi, Hakverdi, Gülden

    “…The use of mycophenolatemofetil (MMF) in the treatment of steroid-dependent nephrotic syndrome (SDNS) is beneficial in decreasing the relapse rate and/or…”
    Get full text
    Journal Article
  2. 2

    Low‐density lipoprotein and blood pressure are important risk factors for vasculopathy in children on dialysis: A single center study by Conkar Tunçay, Seçil, Keskinoğlu, Ahmet, Bulut, İpek Kaplan, Levent, Ertürk, Hakverdi, Gülden, Kabasakal, Caner

    Published in Therapeutic apheresis and dialysis (01-12-2022)
    “…Introduction We searched for risk factors of cardiovascular assessment among children on dialysis. Methods This is a cross‐sectional study of cardiovascular…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Regulatory T-cell Changes in Patients with Steroid-Resistant Nephrotic Syndrome after Rituximab Therapy by Tunçay, Seçil, Hakverdi, Gülden, Şenol, Özgür, Mir, Sevgi

    “…The aim of this study was to investigate the effect of rituximab (RTX) treatment on serum immunoglobulin (Ig) A, G, M levels, and B and CD4+CD25+FoxP3+ [T…”
    Get full text
    Journal Article
  5. 5

    Interleukin-8 is increased in chronic kidney disease in children, but not related to cardiovascular disease by Tunçay, Seçil Conkar, Doğan, Eser, Hakverdi, Gülden, Tutar, Zulal Ülger, Mir, Sevgi

    Published in Brazilian Journal of Nephrology (01-01-2021)
    “…In this study, we aimed to detect the cytokine that is involved in the early stage of chronic kidney disease and associated with cardiovascular disease. We…”
    Get full text
    Journal Article
  6. 6
  7. 7